88家药企“狂”回购:恒瑞、药明、复星们在下什么棋?

E药经理人
16 Apr

仅一季度,A股88家上市药企就花了近40亿回购股份,集采不停、地缘争端不断的持续冲击下,医药股为何长期承压却逆势掀起“回购潮”?撰文| Erin近期,一组公开数据引发热议,“A股上市公司一季度合计回购294亿元,医药生物板块以近40亿元遥遥领先。”2025年一季度实施回购金额居前的行业事实的确如此,E药经理人根据Wind数据统计,今年一季度A股88家上市公司发布股份回购进展,总额达36.46亿元,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10